Mina Gaga Selected Research

Mina Gaga Research Topics

Disease

29	Asthma (Bronchial Asthma) 09/2022 - 05/2005
11	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 05/2005
7	Inflammation (Inflammations) 01/2022 - 05/2009
6	Extensively Drug-Resistant Tuberculosis 01/2019 - 01/2016
4	Lung Neoplasms (Lung Cancer) 09/2021 - 10/2017
3	Hypersensitivity (Allergy) 03/2022 - 12/2015
3	Pneumonia (Pneumonitis) 11/2020 - 10/2013
2	Neoplasms (Cancer) 09/2021 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2020 - 07/2014
2	Airway Remodeling 12/2015 - 08/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 03/2022
1	Melanoma (Melanoma, Malignant) 09/2021
1	Lewis Lung Carcinoma 09/2021
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Disease Progression 09/2021
1	Noncommunicable Diseases 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	COVID-19 11/2020
1	Cytokine Release Syndrome 11/2020
1	Lung Injury 11/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019
1	Pneumothorax 01/2019
1	Pulmonary Tuberculosis 01/2019
1	Hemorrhage 01/2019
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2019
1	Adenocarcinoma 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Granuloma 07/2014
1	Hepatitis 10/2013
1	Transitional Cell Carcinoma 10/2013
1	Jaundice (Icterus) 10/2013
1	Sepsis (Septicemia) 10/2013

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 02/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
6	SteroidsIBA 01/2022 - 01/2007
4	GoldIBA 07/2021 - 01/2007
4	Biological ProductsIBA 01/2020 - 01/2019
3	SmokeIBA 01/2021 - 05/2005
3	Monoclonal AntibodiesIBA 01/2020 - 12/2015
3	Interleukin-5 (Interleukin 5)IBA 01/2020 - 01/2007
3	Pharmaceutical PreparationsIBA 11/2019 - 07/2005
3	Immunoglobulin E (IgE)IBA 12/2016 - 01/2007
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 01/2016
2	mepolizumabIBA 09/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2012
2	CytokinesIBA 09/2021 - 03/2016
2	activin AIBA 09/2021 - 03/2016
2	Omalizumab (Xolair)FDA Link 01/2021 - 12/2015
2	MacrolidesIBA 01/2020 - 01/2007
2	anti-IgE antibodiesIBA 01/2020 - 12/2015
2	Tiotropium Bromide (Spiriva)FDA Link 01/2020 - 01/2016
2	bedaquiline (R207910)IBA 01/2019 - 01/2017
2	indacaterolIBA 01/2018 - 01/2017
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 10/2015
2	Imipenem FDA Link 05/2016 - 01/2016
2	Meropenem (Merrem)FDA LinkGeneric 04/2016 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 01/2016
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2007 - 07/2005
1	TabletsIBA 03/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	PeriostinIBA 01/2021
1	prostaglandin D2 receptorIBA 01/2021
1	fevipiprantIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Thymic Stromal LymphopoietinIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	dupilumabIBA 01/2020
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2020
1	tezepelumabIBA 01/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Calcifediol (Calcidiol)FDA Link 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-13IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	SolutionsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Muscarinic AntagonistsIBA 01/2017
1	PowdersIBA 01/2016
1	FluoroquinolonesIBA 01/2016
1	Bronchodilator Agents (Bronchodilators)IBA 01/2016
1	B-Cell Activating FactorIBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015
1	AcidsIBA 07/2014
1	Granzymes (Granzyme)IBA 10/2013
1	PerforinIBA 10/2013
1	SA 76IBA 07/2013
1	ORALIT (ORS)IBA 07/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2013

Therapy/Procedure

16	Therapeutics 01/2021 - 05/2005
2	Immunotherapy 11/2019 - 10/2013
2	Nebulizers and Vaporizers (Inhaler) 01/2018 - 01/2016
1	Precision Medicine 01/2020
1	Duration of Therapy 04/2018
1	Continuity of Patient Care 09/2015
1	Intravesical Administration 10/2013